REGN7041 / Regeneron - LARVOL DELTA

TITAN: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants (clinicaltrials.gov) - P1/2 | N=1 | Terminated | Sponsor: Regeneron Pharmaceuticals | N=72 ➔ 1 | Trial completion date: Jun 2028 ➔ Jul 2026 | Active, not recruiting ➔ Terminated | Trial primary completion date: Jun 2028 ➔ Jul 2026; Unfavorable benefit-risk assessment

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Ocular Inflammation • Ophthalmology • Uveitis

TITAN: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants (clinicaltrials.gov) - P1/2 | N=72 | Active, not recruiting | Sponsor: Regeneron Pharmaceuticals | Recruiting ➔ Active, not recruiting

Enrollment closed • Ocular Inflammation • Ophthalmology • Uveitis

TITAN: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants (clinicaltrials.gov) - P1/2 | N=72 | Recruiting | Sponsor: Regeneron Pharmaceuticals

Trial initiation date • Ocular Inflammation • Ophthalmology • Uveitis

R7041-NIU-24123: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants (clinicaltrialsregister.eu) - P1/2 | N=5 | Not yet recruiting | Sponsor: Regeneron Pharmaceuticals Inc.

New P1/2 trial • Ocular Inflammation • Ophthalmology • Uveitis